9
IRUS Total
Downloads
  Altmetric

A review of the biomarkers and in vivo models for the diagnosis and treatment of heterotopic ossification following blast and trauma-induced injuries

File Description SizeFormat 
Manuscript.docxAccepted version757.35 kBMicrosoft WordView/Open
Title: A review of the biomarkers and in vivo models for the diagnosis and treatment of heterotopic ossification following blast and trauma-induced injuries
Authors: Kazezian, Z
Bull, AMJ
Item Type: Journal Article
Abstract: Heterotopic ossification (HO) is the process of de novo bone formation in non-osseous tissues. HO can occur following trauma and burns and over 60% of military personnel with blast-associated amputations develop HO. This rate is far higher than in other trauma-induced HO development. This suggests that the blast effect itself is a major contributing factor, but the pathway triggering HO following blast injury specifically is not yet fully identified. Also, because of the difficulty of studying the disease using clinical data, the only sources remain the relevant in vivo models. The aim of this paper is first to review the key biomarkers and signalling pathways identified in trauma and blast induced HO in order to summarize the molecular mechanisms underlying HO development, and second to review the blast injury in vivo models developed. The literature derived from trauma-induced HO suggests that inflammatory cytokines play a key role directing different progenitor cells to transform into an osteogenic class contributing to the development of the disease. This highlights the importance of identifying the downstream biomarkers under specific signalling pathways which might trigger similar stimuli in blast to those of trauma induced formation of ectopic bone in the tissues surrounding the site of the injury. The lack of information in the literature regarding the exact biomarkers leading to blast associated HO is hampering the design of specific therapeutics. The majority of existing blast injury in vivo models do not fully replicate the combat scenario in terms of blast, fracture and amputation; these three usually happen in one insult. Hence, this paper highlights the need to replicate the full effect of the blast in preclinical models to better understand the mechanism of blast induced HO development and to enable the design of a specific therapeutic to supress the formation of ectopic bone.
Issue Date: 1-Feb-2021
Date of Acceptance: 18-Nov-2020
URI: http://hdl.handle.net/10044/1/85838
DOI: 10.1016/j.bone.2020.115765
ISSN: 1873-2763
Publisher: Elsevier
Journal / Book Title: Bone
Volume: 143
Copyright Statement: © 2020 Elsevier Inc. All rights reserved. This manuscript is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International Licence http://creativecommons.org/licenses/by-nc-nd/4.0/
Sponsor/Funder: The Royal British Legion
Funder's Grant Number: BMPF_P60304
Keywords: Science & Technology
Life Sciences & Biomedicine
Endocrinology & Metabolism
Heterotopic ossification (HO)
Ectopic bone
Biomarkers of HO
Signalling pathways of HO
in vivo models of HO
BONE MORPHOGENETIC PROTEIN-2
TOTAL HIP-ARTHROPLASTY
SPINAL-CORD-INJURY
COMBAT-RELATED AMPUTATIONS
ECTOPIC BONE
RISK-FACTORS
OSTEOBLAST DIFFERENTIATION
PHARMACOLOGICAL-TREATMENT
PROGENITOR CELLS
GENE-THERAPY
Biomarkers of HO
Ectopic bone
Heterotopic ossification (HO)
Signalling pathways of HO
in vivo models of HO
Endocrinology & Metabolism
06 Biological Sciences
09 Engineering
11 Medical and Health Sciences
Publication Status: Published
Article Number: ARTN 115765
Online Publication Date: 2020-12-04
Appears in Collections:Bioengineering
Faculty of Engineering



This item is licensed under a Creative Commons License Creative Commons